LEADER 03161cam a22004574a 4500
008 040116s2004 enka b 001 0 eng
010 |a  2004001166 
020 |a 0471498475 (hbk. : alk. paper) 
020 |a 0471499196 (pbk. : alk. paper) 
035 |a (DNLM)101203481 
042 |a pcc 
060 1 0 |a QV 38  |b M717 2004 
082 0 0 |a 615/.7  |2 22 
245 0 0 |a Molecular analysis and genome discovery /  |c edited by Ralph Rapley and Stuart Harbron. 
260 |a Chichester, West Sussex, England ;  |a Hoboken, N.J. :  |b J. Wiley,  |c c2004. 
300 |a xv, 372 p. :  |b ill. ;  |c 24 cm. 
504 |a Includes bibliographical references and index. 
505 0 |a Pharmacogenetics and pharmacogenomics: an overview / W. Kalow -- Quantitative TaqMan real-time PCR: diagnostic and scientific applications / Jörg Dötsch, Ellen Schoof, and Wolfgang Rascher -- Hybridization probes for quantitative PCR / Elaine Lyon -- An overview of genotyping and single nucleotide polymorphisms (SNP) / Ivo Glynne Gut -- High-throughput mutation screening / Paal Skytt Andersen and Lars Allan Larsen -- Determination of nucleic acid sequence by pyrosequencing / Elaine Elahi and Mostafa Ronaghi -- An introduction to DNA chips / Magdalena Gabig-Ciminska and Andrzej Ciminski -- Overview of microarrays in genomic analysis / Janette K. Burgess -- Overview of differential gene expression by high-throughput analysis / Kin-Ying To -- 
505 0 |a Aptamers: powerful molecular tools for therapeutics and diagnostics / Eva Baldrich i Rubio, Monica Campos i Homs, and Ciara K. O'Sullivan -- Chip-based proteomics technology / Mikhail Soloviev, Richard Barry, and Jon Terrett -- Infectomics overview: holistic and integrative studies of infectious diseases / Sheng-He Huang and Ambrose Jong -- The drug discovery process / Roberto Solari -- Structure-based drug discovery / Chen-Chen Kan, Kevin Hambly, and Derek A. Debe -- Protein interaction-targeted drug discovery / Gary Hudes, Sanjay Menon, and Erica A. Golemis -- Overview of quantitative structure-activity relationships (QSAR) / David A. Winkler. 
650 0 |a Molecular diagnosis. 
650 0 |a Genomics. 
650 0 |a Proteomics. 
650 0 |a Pharmacogenomics. 
650 0 |a Polymerase chain reaction. 
650 0 |a DNA microarrays. 
650 1 2 |a Pharmacogenetics  |x methods. 
650 2 2 |a Biological Markers. 
650 2 2 |a Drug Design. 
650 2 2 |a Genetic Techniques. 
650 2 2 |a Pharmaceutical Preparations  |x metabolism. 
650 2 2 |a Quantitative Structure-Activity Relationship. 
700 1 |a Rapley, Ralph. 
700 1 |a Harbron, Stuart. 
856 4 2 |u http://www.loc.gov/catdir/description/wiley041/2004001166.html 
856 4 1 |u http://www.loc.gov/catdir/toc/ecip0414/2004001166.html 
856 4 2 |u http://www.e-streams.com/es0803/es0803_3997.html 
906 |a 7  |b cbc  |c orignew  |d 1  |e ecip  |f 20  |g y-gencatlg 
942 |c BK 
955 |a NLM  |a jc00 2004-01-20 to jc02  |a aa01 2004-02-03  |a ps13 2004-07-01 1 copy rec'd., to CIP ver.; 
999 |c 151771  |d 151771 
952 |0 0  |1 0  |4 0  |6 615_700000000000000_RAP_M  |7 0  |9 162218  |a BIO  |b BIO  |c ST1  |d 2011-01-20  |g 0.00  |i 1260  |l 0  |o 615.7 RAP/ M  |p BIO1260  |r 2013-12-28  |w 2018-08-10  |y BK